• Home
  • Medical Devices
Global Obesity Treatment Devices Market Research Report 2021

Global Obesity Treatment Devices Market Research Report 2021

Report Code: KNJ774610 | No. of Pages: 121 | Category: Medical Devices
Publisher: QYResearch | Date of Publish: Jun-2021 
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    Gastric Banding Systems
    Gastric Balloon Systems
    Gastric Electrical Stimulation Systems
    Gastric Emptying Systems or Gastric Aspiration Systems
    Other

Segment by Application
    Hospitals
    Clinics
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Allergan, Inc.
    Apollo Endosurgery, Inc.
    Aspire Medical, Inc. (Aspire Bariatrics)
    Boston Scientific Corp.
    Cousin Biotech
    CR Bard, Inc.
    EnteroMedics, Inc.
    GI Dynamics, Inc.
    GI Windows, Inc.
    Johnson & Johnson
    Leptos Biomedical
    Mediflex Surgical Products
    Medtronic, Inc.
    ReShape Medical, Inc.
    Satiety, Inc.
    Spatz FGIA, Inc.
    TransEnterix, Inc.
1 Obesity Treatment Devices Market Overview
    1.1 Product Overview and Scope of Obesity Treatment Devices
    1.2 Obesity Treatment Devices Segment by Type
        1.2.1 Global Obesity Treatment Devices Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Gastric Banding Systems
        1.2.3 Gastric Balloon Systems
        1.2.4 Gastric Electrical Stimulation Systems
        1.2.5 Gastric Emptying Systems or Gastric Aspiration Systems
        1.2.6 Other
    1.3 Obesity Treatment Devices Segment by Application
        1.3.1 Obesity Treatment Devices Sales Comparison by Application: (2021-2027)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global Obesity Treatment Devices Market Size Estimates and Forecasts
        1.4.1 Global Obesity Treatment Devices Revenue 2016-2027
        1.4.2 Global Obesity Treatment Devices Sales 2016-2027
        1.4.3 Obesity Treatment Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Obesity Treatment Devices Market Competition by Manufacturers
    2.1 Global Obesity Treatment Devices Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Obesity Treatment Devices Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Obesity Treatment Devices Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Obesity Treatment Devices Manufacturing Sites, Area Served, Product Type
    2.5 Obesity Treatment Devices Market Competitive Situation and Trends
        2.5.1 Obesity Treatment Devices Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Obesity Treatment Devices Players Market Share by Revenue
        2.5.3 Global Obesity Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Obesity Treatment Devices Retrospective Market Scenario by Region
    3.1 Global Obesity Treatment Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Obesity Treatment Devices Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Obesity Treatment Devices Market Facts & Figures by Country
        3.3.1 North America Obesity Treatment Devices Sales by Country
        3.3.2 North America Obesity Treatment Devices Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Obesity Treatment Devices Market Facts & Figures by Country
        3.4.1 Europe Obesity Treatment Devices Sales by Country
        3.4.2 Europe Obesity Treatment Devices Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Obesity Treatment Devices Market Facts & Figures by Region
        3.5.1 Asia Pacific Obesity Treatment Devices Sales by Region
        3.5.2 Asia Pacific Obesity Treatment Devices Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Obesity Treatment Devices Market Facts & Figures by Country
        3.6.1 Latin America Obesity Treatment Devices Sales by Country
        3.6.2 Latin America Obesity Treatment Devices Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Obesity Treatment Devices Market Facts & Figures by Country
        3.7.1 Middle East and Africa Obesity Treatment Devices Sales by Country
        3.7.2 Middle East and Africa Obesity Treatment Devices Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Obesity Treatment Devices Historic Market Analysis by Type
    4.1 Global Obesity Treatment Devices Sales Market Share by Type (2016-2021)
    4.2 Global Obesity Treatment Devices Revenue Market Share by Type (2016-2021)
    4.3 Global Obesity Treatment Devices Price by Type (2016-2021)

5 Global Obesity Treatment Devices Historic Market Analysis by Application
    5.1 Global Obesity Treatment Devices Sales Market Share by Application (2016-2021)
    5.2 Global Obesity Treatment Devices Revenue Market Share by Application (2016-2021)
    5.3 Global Obesity Treatment Devices Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Allergan, Inc.
        6.1.1 Allergan, Inc. Corporation Information
        6.1.2 Allergan, Inc. Description and Business Overview
        6.1.3 Allergan, Inc. Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Allergan, Inc. Product Portfolio
        6.1.5 Allergan, Inc. Recent Developments/Updates
    6.2 Apollo Endosurgery, Inc.
        6.2.1 Apollo Endosurgery, Inc. Corporation Information
        6.2.2 Apollo Endosurgery, Inc. Description and Business Overview
        6.2.3 Apollo Endosurgery, Inc. Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Apollo Endosurgery, Inc. Product Portfolio
        6.2.5 Apollo Endosurgery, Inc. Recent Developments/Updates
    6.3 Aspire Medical, Inc. (Aspire Bariatrics)
        6.3.1 Aspire Medical, Inc. (Aspire Bariatrics) Corporation Information
        6.3.2 Aspire Medical, Inc. (Aspire Bariatrics) Description and Business Overview
        6.3.3 Aspire Medical, Inc. (Aspire Bariatrics) Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Aspire Medical, Inc. (Aspire Bariatrics) Product Portfolio
        6.3.5 Aspire Medical, Inc. (Aspire Bariatrics) Recent Developments/Updates
    6.4 Boston Scientific Corp.
        6.4.1 Boston Scientific Corp. Corporation Information
        6.4.2 Boston Scientific Corp. Description and Business Overview
        6.4.3 Boston Scientific Corp. Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Boston Scientific Corp. Product Portfolio
        6.4.5 Boston Scientific Corp. Recent Developments/Updates
    6.5 Cousin Biotech
        6.5.1 Cousin Biotech Corporation Information
        6.5.2 Cousin Biotech Description and Business Overview
        6.5.3 Cousin Biotech Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Cousin Biotech Product Portfolio
        6.5.5 Cousin Biotech Recent Developments/Updates
    6.6 CR Bard, Inc.
        6.6.1 CR Bard, Inc. Corporation Information
        6.6.2 CR Bard, Inc. Description and Business Overview
        6.6.3 CR Bard, Inc. Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 CR Bard, Inc. Product Portfolio
        6.6.5 CR Bard, Inc. Recent Developments/Updates
    6.7 EnteroMedics, Inc.
        6.6.1 EnteroMedics, Inc. Corporation Information
        6.6.2 EnteroMedics, Inc. Description and Business Overview
        6.6.3 EnteroMedics, Inc. Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 EnteroMedics, Inc. Product Portfolio
        6.7.5 EnteroMedics, Inc. Recent Developments/Updates
    6.8 GI Dynamics, Inc.
        6.8.1 GI Dynamics, Inc. Corporation Information
        6.8.2 GI Dynamics, Inc. Description and Business Overview
        6.8.3 GI Dynamics, Inc. Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 GI Dynamics, Inc. Product Portfolio
        6.8.5 GI Dynamics, Inc. Recent Developments/Updates
    6.9 GI Windows, Inc.
        6.9.1 GI Windows, Inc. Corporation Information
        6.9.2 GI Windows, Inc. Description and Business Overview
        6.9.3 GI Windows, Inc. Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 GI Windows, Inc. Product Portfolio
        6.9.5 GI Windows, Inc. Recent Developments/Updates
    6.10 Johnson & Johnson
        6.10.1 Johnson & Johnson Corporation Information
        6.10.2 Johnson & Johnson Description and Business Overview
        6.10.3 Johnson & Johnson Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Johnson & Johnson Product Portfolio
        6.10.5 Johnson & Johnson Recent Developments/Updates
    6.11 Leptos Biomedical
        6.11.1 Leptos Biomedical Corporation Information
        6.11.2 Leptos Biomedical Obesity Treatment Devices Description and Business Overview
        6.11.3 Leptos Biomedical Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Leptos Biomedical Product Portfolio
        6.11.5 Leptos Biomedical Recent Developments/Updates
    6.12 Mediflex Surgical Products
        6.12.1 Mediflex Surgical Products Corporation Information
        6.12.2 Mediflex Surgical Products Obesity Treatment Devices Description and Business Overview
        6.12.3 Mediflex Surgical Products Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Mediflex Surgical Products Product Portfolio
        6.12.5 Mediflex Surgical Products Recent Developments/Updates
    6.13 Medtronic, Inc.
        6.13.1 Medtronic, Inc. Corporation Information
        6.13.2 Medtronic, Inc. Obesity Treatment Devices Description and Business Overview
        6.13.3 Medtronic, Inc. Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Medtronic, Inc. Product Portfolio
        6.13.5 Medtronic, Inc. Recent Developments/Updates
    6.14 ReShape Medical, Inc.
        6.14.1 ReShape Medical, Inc. Corporation Information
        6.14.2 ReShape Medical, Inc. Obesity Treatment Devices Description and Business Overview
        6.14.3 ReShape Medical, Inc. Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 ReShape Medical, Inc. Product Portfolio
        6.14.5 ReShape Medical, Inc. Recent Developments/Updates
    6.15 Satiety, Inc.
        6.15.1 Satiety, Inc. Corporation Information
        6.15.2 Satiety, Inc. Obesity Treatment Devices Description and Business Overview
        6.15.3 Satiety, Inc. Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 Satiety, Inc. Product Portfolio
        6.15.5 Satiety, Inc. Recent Developments/Updates
    6.16 Spatz FGIA, Inc.
        6.16.1 Spatz FGIA, Inc. Corporation Information
        6.16.2 Spatz FGIA, Inc. Obesity Treatment Devices Description and Business Overview
        6.16.3 Spatz FGIA, Inc. Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 Spatz FGIA, Inc. Product Portfolio
        6.16.5 Spatz FGIA, Inc. Recent Developments/Updates
    6.17 TransEnterix, Inc.
        6.17.1 TransEnterix, Inc. Corporation Information
        6.17.2 TransEnterix, Inc. Obesity Treatment Devices Description and Business Overview
        6.17.3 TransEnterix, Inc. Obesity Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 TransEnterix, Inc. Product Portfolio
        6.17.5 TransEnterix, Inc. Recent Developments/Updates

7 Obesity Treatment Devices Manufacturing Cost Analysis
    7.1 Obesity Treatment Devices Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Obesity Treatment Devices
    7.4 Obesity Treatment Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Obesity Treatment Devices Distributors List
    8.3 Obesity Treatment Devices Customers

9 Obesity Treatment Devices Market Dynamics
    9.1 Obesity Treatment Devices Industry Trends
    9.2 Obesity Treatment Devices Growth Drivers
    9.3 Obesity Treatment Devices Market Challenges
    9.4 Obesity Treatment Devices Market Restraints

10 Global Market Forecast
    10.1 Obesity Treatment Devices Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Obesity Treatment Devices by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Obesity Treatment Devices by Type (2022-2027)
    10.2 Obesity Treatment Devices Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Obesity Treatment Devices by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Obesity Treatment Devices by Application (2022-2027)
    10.3 Obesity Treatment Devices Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Obesity Treatment Devices by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Obesity Treatment Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com